EISAI CO., LTD. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 6,779 JPY | -1.27% |
|
+1.35% | -3.87% |
| 05-16 | Eisai's Attributable Profit Falls 23.5% in Fiscal 2024 | MT |
| 05-15 | BioArctic, Eisai Launch Rolling US FDA Application for Leqembi's Maintenance Dosing | MT |
Presenter SpeechUnknown Executive (Executives)Thank you for waiting, the time has come. We wou...
This article is reserved for subscribers
Signed up already?
Log InNot subscribed yet?
Subscribe
Eisai Company specializes in the manufacturing and marketing of pharmaceutical products. Net sales break down by family of products as follows:
- pharmaceutical products (87.7%): prescribed drugs, health products, etc.;
- other (12.3%): food additives, chemical products, etc.
Net sales are distributed geographically as follows: Japan (46.2%), Europe (19.5%), Americas (15.5%), China (10.3%) and other (8.4%).
Sector
Pharmaceuticals
Calendar
2024-11-05
- Q2 2024 Earnings Release (Projected)
Related indices
Trading Rating
Investor Rating
ESG Refinitiv
A-
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
14
Last Close Price
6,779
JPY
Average target price
8,100
JPY
Spread / Average Target
+19.49%
EPS Revisions
| 1st Jan change | Capi. | |
|---|---|---|
| -3.87% | 12.68B | |
| +32.08% | 694B | |
| +29.39% | 593B | |
| -1.52% | 371B | |
| +19.92% | 331B | |
| +7.18% | 290B | |
| +14.25% | 239B | |
| -3.03% | 209B | |
| +10.02% | 209B | |
| +8.33% | 169B |
- Stock Market
- Equities
- 4523 Stock
- News Eisai Co., Ltd.
- Transcript : Eisai Co., Ltd., Q3 2015 Earnings Call, Jan 30, 2015